Your browser doesn't support javascript.
loading
The dual inhibitor Sacubitril-valsartan ameliorate high-fat high-fructose-induced metabolic disorders in rats superiorly compared to valsartan only.
Abo-Khookh, Ahmed M; Ghoneim, Hamdy A; Abdelaziz, Rania R; Nader, Manar A; Shawky, Noha M.
Affiliation
  • Abo-Khookh AM; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
  • Ghoneim HA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
  • Abdelaziz RR; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
  • Nader MA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
  • Shawky NM; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
J Pharm Pharmacol ; 75(6): 846-858, 2023 Jun 05.
Article in En | MEDLINE | ID: mdl-36966365
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart Failure / Metabolic Diseases Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Pharm Pharmacol Year: 2023 Type: Article Affiliation country: Egypt
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart Failure / Metabolic Diseases Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Pharm Pharmacol Year: 2023 Type: Article Affiliation country: Egypt